Serveur d'exploration Covid (26 mars) - Analysis (an2020)

Index « AbsEn.i » - entrée « medicine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
medicinal < medicine < medicines  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]
Ident.Authors (with country if any)Title
000039 (2020) [Recommendation on the modernization of disease control and prevention].
000057 (2020) Kaijin Xu [République populaire de Chine] ; Hongliu Cai [République populaire de Chine] ; Yihong Shen [République populaire de Chine] ; Qin Ni [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Shaohua Hu [République populaire de Chine] ; Jianping Li [République populaire de Chine] ; Huafen Wang [République populaire de Chine] ; Liang Yu [République populaire de Chine] ; He Huang [République populaire de Chine] ; Yunqing Qiu [République populaire de Chine] ; Guoqing Wei [République populaire de Chine] ; Qiang Fang [République populaire de Chine] ; Jianying Zhou [République populaire de Chine] ; Jifang Sheng [République populaire de Chine] ; Tingbo Liang [République populaire de Chine] ; Lanjuan Li [République populaire de Chine][Management of corona virus disease-19 (COVID-19): the Zhejiang experience].
000068 (2020) F B Tao [République populaire de Chine][Healing the schism between public health and medicine, promoting the integration of prevention and treatment].
000077 (2020) [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
000078 (2020) [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].
000099 (2020) D. Thomas-Rüddel [Allemagne] ; J. Winning [Allemagne] ; P. Dickmann [Allemagne] ; D. Ouart [Allemagne] ; A. Kortgen [Allemagne] ; U. Janssens [Allemagne] ; M. Bauer [Allemagne][Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020].
000133 (2020) [An update on the epidemiological characteristics of novel coronavirus pneumonia(COVID-19)].
000188 (2020) Evelyne Bischof [République populaire de Chine] ; Guoting Chen [République populaire de Chine] ; Maria Teresa Ferretti [Suisse]Understanding COVID-19 new diagnostic guidelines - a message of reassurance from an internal medicine doctor in Shanghai.
000207 (2020) Jun-Ling Ren [République populaire de Chine] ; Ai-Hua Zhang [République populaire de Chine] ; Xi-Jun Wang [République populaire de Chine]Traditional Chinese medicine for COVID-19 treatment.
000271 (2020) Giuseppe Lippi [Italie] ; Mario Plebani [Italie]The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks.
000278 (2020) Yonathan Freund [France]The challenge of emergency medicine facing the COVID-19 outbreak.
000559 (2020) Yadi Zhou [États-Unis] ; Yuan Hou [États-Unis] ; Jiayu Shen [États-Unis] ; Yin Huang [États-Unis] ; William Martin [États-Unis] ; Feixiong Cheng [États-Unis]Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
000605 (2020) Li Runfeng [République populaire de Chine] ; Hou Yunlong [République populaire de Chine] ; Huang Jicheng [République populaire de Chine] ; Pan Weiqi [République populaire de Chine] ; Ma Qinhai [République populaire de Chine] ; Shi Yongxia [République populaire de Chine] ; Li Chufang [République populaire de Chine] ; Zhao Jin [République populaire de Chine] ; Jia Zhenhua [République populaire de Chine] ; Jiang Haiming [République populaire de Chine] ; Zheng Kui [République populaire de Chine] ; Huang Shuxiang [République populaire de Chine] ; Dai Jun [République populaire de Chine] ; Li Xiaobo [République populaire de Chine] ; Hou Xiaotao [République populaire de Chine] ; Wang Lin [République populaire de Chine] ; Zhong Nanshan [République populaire de Chine] ; Yang Zifeng [République populaire de Chine]Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).
000668 (2020) Paolo Boldrini [Oman] ; Andrea Bernetti [Italie] ; Pietro Fiore [Italie]Impact of COVID-19 outbreak on rehabilitation services and Physical and Rehabilitation Medicine (PRM) physicians' activities in Italy. An official document of the Italian PRM Society (SIMFER).
000825 (2020) Hongzhou Lu [République populaire de Chine]Drug treatment options for the 2019-new coronavirus (2019-nCoV).
000912 (2020) Abi RimmerCovid-19: GPs can stop health checks for over 75s and routine medicine reviews.
000958 (2020) L. Meng [République populaire de Chine] ; F. Hua [République populaire de Chine] ; Z. Bian [République populaire de Chine]Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine.
000975 (2020) B. Robson [États-Unis, Royaume-Uni]Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus
000987 (2020) Li Ni [République populaire de Chine] ; Ling Zhou [République populaire de Chine] ; Min Zhou [République populaire de Chine] ; Jianping Zhao [République populaire de Chine] ; Dao Wen Wang [République populaire de Chine]Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan
000A18 (2020) Zhenwei Wang [République populaire de Chine] ; Xiaorong Chen [République populaire de Chine] ; Yunfei Lu [République populaire de Chine] ; Feifei Chen [République populaire de Chine] ; Wei Zhang [République populaire de Chine]Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.
000A71 (2020) Hui Luo [République populaire de Chine] ; Qiao-Ling Tang [République populaire de Chine] ; Ya-Xi Shang [République populaire de Chine] ; Shi-Bing Liang [République populaire de Chine] ; Ming Yang [République populaire de Chine] ; Nicola Robinson [République populaire de Chine] ; Jian-Ping Liu [République populaire de Chine]Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/an2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i -k "medicine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/AbsEn.i  \
                -Sk "medicine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    an2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    medicine
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021